Literature DB >> 17699239

Mechanisms and role of HLA and non-HLA alloantibodies.

Kathryn J Tinckam1, Anil Chandraker.   

Abstract

The role of alloantibodies against HLA and non-HLA targets is becoming increasingly recognized as critical in the pathogenesis of acute and chronic renal allograft outcomes. This review discusses the antigenic targets, the mechanisms of T and B cell activation that result in the production of antibody, the complement cascade, methods of antibody detection, and the evidence that alloantibody-mediated mechanisms are active in acute and chronic rejection.

Mesh：

Substances：

Year:  2006        PMID： 17699239     DOI： 10.2215/CJN.00270106

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


  9 in total

1.  Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation.

Authors:  Nataraju Angaswamy; Deepti Saini; Sabarinathan Ramachandran; Dilip S Nath; Donna Phelan; Ramsey Hachem; Elbert Trulock; G Alexander Patterson; T Mohanakumar
Journal:  Hum Immunol       Date:  2010-03-16       Impact factor: 2.850

2.  The future of cardiac transplantation.

Authors:  Kevin Koomalsingh; Jon A Kobashigawa
Journal:  Ann Cardiothorac Surg       Date:  2018-01

3.  The Assessment and Outcomes of Crossmatching in Lung Transplantation in Korean Patients.

Authors:  Ha Eun Kim; Young Ho Yang; Hyo Chae Paik; Su Jin Jeong; Song Yee Kim; Moo Suk Park; Jin Gu Lee
Journal:  J Korean Med Sci       Date:  2022-06-06       Impact factor: 5.354

4.  Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients.

Authors:  Scott M Sutherland; Li Li; Tara K Sigdel; Persis P Wadia; David B Miklos; Atul J Butte; Minnie M Sarwal
Journal:  Kidney Int       Date:  2009-10-07       Impact factor: 10.612

Review 5.  Endothelial cells in allograft rejection.

Authors:  Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

6.  Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I.

Authors:  Jose M Morales; Jose Angel Martinez-Flores; Manuel Serrano; Maria José Castro; Francisco Javier Alfaro; Florencio García; Miguel Angel Martínez; Amado Andrés; Esther González; Manuel Praga; Estela Paz-Artal; Antonio Serrano
Journal:  J Am Soc Nephrol       Date:  2014-07-28       Impact factor: 10.121

7.  Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses.

Authors:  Michele Carvello; Alessandra Petrelli; Andrea Vergani; Kang Mi Lee; Sara Tezza; Melissa Chin; Elena Orsenigo; Carlo Staudacher; Antonio Secchi; Kyri Dunussi-Joannopoulos; Mohamed H Sayegh; James F Markmann; Paolo Fiorina
Journal:  Diabetes       Date:  2011-11-10       Impact factor: 9.461

8.  Suppression of liver transplant rejection by anti-donor MHC antibodies via depletion of donor immunogenic dendritic cells.

Authors:  Hisashi Ueta; Xue-Dong Xu; Bin Yu; Yusuke Kitazawa; Enqiao Yu; Yoshiaki Hara; Miwa Morita-Nakagawa; Shu Zhou; Yasushi Sawanobori; Satoshi Ueha; Kazuhito Rokutan; Toshiya Tanaka; Nobuko Tokuda; Kouji Matsushima; Kenjiro Matsuno
Journal:  Int Immunol       Date:  2021-04-22       Impact factor: 4.823

Review 9.  In praise of arrays.

Authors:  Lihua Ying; Minnie Sarwal
Journal:  Pediatr Nephrol       Date:  2008-06-21       Impact factor: 3.714
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.